Feel Therapeutics

Feel Therapeutics develops an AI-enabled digital precision medicine platform for mental health, aimed at introducing objective measurement into the diagnosis, management and care of psychiatric conditions. The platform collects physiological, digital and clinical data continuously from wearables, digital health apps, mobile phones and clinician dashboards, and applies proprietary algorithms to compute markers and metrics across mood, stress, sleep, psychomotor activity and cognitive functioning.

Those measures are integrated into evidence-based, personalized digital therapeutic, patient support and wellness programs, with real-time interventions intended to reach patients at their "point of need" rather than only at the point of care. The company's product set includes Feel 360 (24/7 passive monitoring for clinical trials and real-world studies), Feel RxPal (adherence and patient engagement), Feel DTx (precision interventions), Feel well (stress, sleep and emotional wellbeing) and Feel RPM (remote patient monitoring).

Business model

Feel Therapeutics positions its monitoring and digital therapeutic platform as a partner offering across the life sciences spectrum, with stated case-study segments covering drug-plus programs, contract research organizations, real-world evidence, clinical development and research, employers, and health plans and insurers.

Traction

Published evidence includes a Nature Digital Medicine publication on a wearable AI digital mental health program for depression and anxiety, outcomes studies for Feel DTx in depression, anxiety and ADHD populations, and work on digital biomarkers for ADHD and on nature-based interventions and citizen wellbeing monitoring.